|
|
(4 intermediate revisions not shown) |
Line 1: |
Line 1: |
- | ===Bright Red Rashes===
| + | R5Wral Say, you got a nice article.Much thanks again. |
- | *There are five primary players in bright red rashes:
| + | |
- | **Urticaria
| + | |
- | **Erythema multiforme
| + | |
- | **Morbilliform eruptions
| + | |
- | **Lupus erythematosus
| + | |
- | **Dermatomyositis
| + | |
- | | + | |
- | ====General tendencies====
| + | |
- | *In general, vascular reactions to insult can be described by color, topography, and time course:
| + | |
- | **Color: redness = erythema, results from excessive blood flow
| + | |
- | **Topography: raised lesions result from edmea
| + | |
- | **Time course: a reaction can be described as dynamic = evanescent
| + | |
- | ***Note that evanescent means "soon passing out of sight or memory"
| + | |
- | *These three classic vascular reactions ('''erythema, edema, and evanescent''') best describe urticaria, erythema multiforme, and morbilliform reactions
| + | |
- | | + | |
- | ====Urticaria====
| + | |
- | *Urticaria is an '''allergic reaction''' that results in a bright red rash.
| + | |
- | *Urticaria is colloquially known as "hives"
| + | |
- | **The offending '''antigen is usually from a virus, a food, or a drug'''
| + | |
- | **Physical factors can also induce urticaria (think "SPACE"): sun exposure, pressure, aquagenic, cold, exercise
| + | |
- | *Pathogenesis of urticaria:
| + | |
- | **Induction of immune response results in a dilated (erythema), leaky (edema) vascular state that can be readily changed (evanescent)
| + | |
- | **Urticaria's EEE state is '''primarily driven by histamine''' acting on small dermal vessels
| + | |
- | **'''Purpura can result if''' immune complexes damage endothelium to the extent that '''RBCs escape into the tissue'''
| + | |
- | ***Purpura generally lasts more than 24 hours at a single location
| + | |
- | *The rash of urticaria is often described as being '''annular'''.
| + | |
- | | + | |
- | | + | |
- | *http://www.urticare.com/site/urticare/images/basic_theme/back.gif
| + | |
- | *http://images.paraorkut.com/img/health/images/u/urticaria-1944.jpg
| + | |
- | *http://images.ddccdn.com/enc/images/images/en/hives-urticaria-close-up-1651.jpg
| + | |
- | *http://www.rash-pictures.com/images/4/488.jpg
| + | |
- | | + | |
- | ====Erythema Multiforme====
| + | |
- | *Erythema multiforme is an '''allergic reaction''' that results in a bright red rash.
| + | |
- | **Note that both urticaria and EM are allergic reactions.
| + | |
- | *Erythema multiforme is distinct from urticaria by its '''immune complexes''' and its '''apoptotic cytotoxic T cells'''.
| + | |
- | *Erythema multiforme is classified as minor and major based on how severe the manifestation.
| + | |
- | **'''EM minor is usually caused by herpes simplex virus''', especially when EM is recurrent.
| + | |
- | **'''EM major is usually caused by drugs'''
| + | |
- | *EM Major has several named causes / syndromes: '''Stevens-Johnson syndrome''' and '''Toxic Epidermal Necrolysis'''
| + | |
- | **Both SJS and TEN are (usually) allergic reactions to drugs that result in necrolysis of keratinocytes of the lower epidermis.
| + | |
- | **Some consider TEN a more severe form or SJS.
| + | |
- | *EM presentation:
| + | |
- | **Target lesions on palsm
| + | |
- | **Oral mucosal involvement
| + | |
- | **http://medicalimages.allrefer.com/large/erythema-multiforme-target-lesions-on-the-palm.jpg
| + | |
- | **http://im.unboundmedicine.com/medicine/ub/image?na=app:16010:ch18_8.bmp
| + | |
- | **http://www.ebmedicine.net/media_library/aboutUs/Erythema%20Multiforme%20Pediactric%20Emergency%20Medicine%20Practice.JPG
| + | |
- | **http://www.dermatopedia.com/wp-content/themes/dermatopedia/dermimages/4774_Erythema_Multiforme.jpg
| + | |
- | **http://www.dermweb.com/hairnailsmucousmembranes/graphics/jpegs/Untitled-8a.jpg
| + | |
- | **http://www.acponline.org/graphics/bioterro/e_minor.jpg
| + | |
- | | + | |
- | | + | |
- | *Stevens-Johnson Syndrome images:
| + | |
- | **SJS presents with '''widespread "targetoid" lesions'''
| + | |
- | ***Note that these targetoid lesions are different than the target lesions in classical EM presentation
| + | |
- | **http://missinglink.ucsf.edu/lm/DermatologyGlossary/img/Dermatology%20Glossary/Glossary%20Clinical%20Images/Stevens_Johnson-28.jpg
| + | |
- | **http://www.nursinghomesabuseblog.com/uploads/image/Picture%2023.png
| + | |
- | **http://rad.usuhs.mil/derm/lecture_notes/Images/Stevens_Johnson.JPG
| + | |
- | **http://img.medscape.com/fullsize/migrated/565/823/edm565823.fig2.jpg
| + | |
- | **http://www.joeway.co.uk/images/stevenjohnsons2.jpg
| + | |
- | | + | |
- | =====Target lesions versus Targe''toid'' lesions=====
| + | |
- | *Target lesions:
| + | |
- | **Have '''concentric circles''', especially when there are three concentric circles
| + | |
- | **Have central duskiness or a central blister
| + | |
- | **Have a relatively wide pale circle in between
| + | |
- | **Have an outer, thin, moderately erythematous circle
| + | |
- | **http://www.aic.cuhk.edu.hk/web8/0024_erythema_multiforme.JPG
| + | |
- | **http://dermgunner.com/wp-content/uploads/2010/09/target_lesions_of_erythema_multiforme.jpg
| + | |
- | **http://images.medicinenet.com/images/image_collection/skin/erythema-multiforme-minor.jpg
| + | |
- | **http://drugster.info/img/ail/2957_2979_1.JPG
| + | |
- | **http://drugster.info/img/ail/2957_2979_3.jpg
| + | |
- | **http://www.meddean.luc.edu/lumen/MedEd/medicine/dermatology/melton/erthmul1.jpg
| + | |
- | | + | |
- | | + | |
- | *Targetoid lesions:
| + | |
- | **Suggest zonality '''but don't have 3 distinct concentric circles'''
| + | |
- | **http://upload.wikimedia.org/wikipedia/commons/thumb/6/68/EMminor09.JPG/230px-EMminor09.JPG
| + | |
- | **http://dermnetnz.org/reactions/img/ermulti1-s.jpg
| + | |
- | **http://dermatology.cdlib.org/1508/articles/2008102101/1.jpg
| + | |
- | | + | |
- | | + | |
- | ====Morbilliform Reactions====
| + | |
- | *Morbilliform reaction is '''through to be a T-cell mediated hypersensitivity''' to drugs or pathogens.
| + | |
- | *Etiology can be drugs or pathogens
| + | |
- | **Many different drugs (including antibiotics) can cause morbilliform reactions
| + | |
- | **Many pathogens can cause morbilliform reactions; usually enterovirus or group A streptococcus
| + | |
- | *One diagnosis the etiology by culturing the "company" kept by the rash
| + | |
- | *Morbilliform reaction manifests same symptoms regardless of causative agent
| + | |
- | *Morbilliform reaction is '''less evanescent''' than multifomre erythema and urticaria
| + | |
- | *Morbilliform reaction is characterized by '''truncal predominance'''
| + | |
- | **Recall that urticaria could show up anywhere and multiform erythema usually involved the oral mucosa and palms of the hands
| + | |
- | *Morbilliform is marked by its '''maculopapular rash'''
| + | |
- | **Recall that a [http://editthis.info/iusmicm/Dermatology_-_Introduction#Macule_.2F_Patch macule] is NOT raised but is discolored and that a [http://editthis.info/iusmicm/Dermatology_-_Introduction#Papule_.2F_Plaque papule] IS raised but not necessarily discolored.
| + | |
- | ***http://www.aafp.org/afp/20000815/804_f1.jpg
| + | |
- | ***http://eso-cdn.bestpractice.bmj.com/best-practice/images/bp/en-gb/774-2_default.jpg
| + | |
- | | + | |
- | =====Viral Exanthems=====
| + | |
- | *Most viral exanthems manifest as ''morbilliform reactions'' ('''except for varicella''').
| + | |
- | **Recall that an exanthem is a skin eruption secondary to systemic disease.
| + | |
- | **Recall that varicella is a viral infection with herpes.
| + | |
- | *Recall the viral agents that cause the classic pediatric exanthems:
| + | |
- | **'''These all cause MORBILLIFORM reactions'''
| + | |
- | **Rubeola (Measles, paramyxovirus infection): cough, coryza, conjunctivitis, koplik spots
| + | |
- | ***Rubeola is a systemic infection by paramyxovirus of the genus Morbillivirus
| + | |
- | **Rubella (German Measles, rubella virus infection): 3 day progression, progresses toward cephalocaudal poles
| + | |
- | **Roseola (Roseola Infantum, roseola virus infection): fever, followed with '''rash when "defervesce"'''
| + | |
- | **Mononucleosis: fever, fatigue, (f)pharyngitis, adenopathy, liver / spleen involvement
| + | |
- | **Fifth disease (Erythema infectiosum): slapped cheeks, fishnet erythema, recurrence
| + | |
- | ***An example of "multiple stages" seen in many viral exanthems
| + | |
- | | + | |
- | | + | |
- | *Viral exanthums are characterized by: "dew drop on rose petal" formation, umbilicated vesicles, and multiple stages:
| + | |
- | **http://dermnetnz.org/img/umbilicated-s.jpg
| + | |
- | **http://www.elsevierimages.com/images/vpv/000/000/037/37056-0550x0475.jpg
| + | |
- | **http://203.64.79.70/DERMATOLOGY/fac/img0023.jpg
| + | |
- | | + | |
- | ====Lupus Erythematous====
| + | |
- | *Lupus erythematous is an autoimmine disease
| + | |
- | *There are three types of lupus: systemic (SLE), discoid (DLE), and subacute cutaneous (SCLE)
| + | |
- | **Systemic and subacute cutaneous can be '''induced by drugs'''
| + | |
- | *'''All three types of SLE are considered ''idiopathic'''''.
| + | |
- | **A genetic predisposition has been demonstrated.
| + | |
- | *SLE (systemic lupus erythematous) requires 4 of 11 ARA criteria be met.
| + | |
- | *DLE (discoid lupus erythematous) is '''primarily cutaneous''' in manifestation.
| + | |
- | *SCLE (subacute cutaneous lupus erythematous); subacute means it is not quite acute or chronic.
| + | |
- | *Pathogenesis of lupus eyrthmatous is though to be '''UV radiation induced'' and involves formation of '''immune complexes'''.
| + | |
- | | + | |
- | =====Systemic lupus erythematous=====
| + | |
- | *
| + | |
- | | + | |
- | | + | |
- | Lupus Erythematosus Background Information
| + | |
- | Defining the spectrum •
| + | |
- | SLE (systemic lupus erythematosus) 4 of 11 ARA criteria
| + | |
- | | + | |
- | •
| + | |
- | DLE (discoid lupus erythematosus) primarily cutaneous
| + | |
- | | + | |
- | •
| + | |
- | SCLE (subacute cutaneous lupus erythematosus) Etiology
| + | |
- | | + | |
- | •
| + | |
- | Most are idiopathic … genetic susceptibility
| + | |
- | | + | |
- | •
| + | |
- | Some are drug-induced (SLE or SCLE) Pathogenesis
| + | |
- | | + | |
- | •
| + | |
- | UV radiation-induced, immune complex disorder
| + | |
- | | + | |
- | | + | |
- | | + | |
- | | + | |
- | Systemic Lupus Erythematosus ARA Diagnostic Criteria
| + | |
- | Skin and mucosal criteria (DUMP) Discoid lupus Ulcers (oropharyngeal, usually no pain) Malar rash Photosensitivity
| + | |
- | | + | |
- | Systemic criteria (minimal role of laboratory testing) Arthritis CNS (seizures, psychosis) Serositis (pleural, pericardial)
| + | |
- | | + | |
- | Laboratory abnormalities Antinuclear antibodies Other serologic tests (dsDNA, anti-Sm) Hematologic (CBC) Renal (UA, 24-hour
| + | |
- | | + | |
- | urine protein)
| + | |
- | | + | |
- | Lupus Erythematosus – Clinical Features SLE with malar rash, photosensitivity
| + | |
- | 08
| + | |
- | | + | |
- | Lupus Erythematosus – Clinical Features SLE with photosensitivity, spillover to unexposed sites
| + | |
- | 09
| + | |
- | | + | |
- | Lupus Erythematosus – Clinical Features DLE with scarring alopecia, erythema suggesting still active
| + | |
- | 10
| + | |
- | | + | |
- | Lupus Erythematosus – Clinical Features DLE with erythema, edema, crusting, conchal bowl involvement; with scarring as end
| + | |
- | | + | |
- | result
| + | |
- | 11
| + | |
- | | + | |
- | Dermatomyositis Background Information
| + | |
- | Defining the spectrum •
| + | |
- | Polymyositis (no skin features)
| + | |
- | | + | |
- | •
| + | |
- | Dermatomyositis (skin + muscle) both adult and juvenile Etiology
| + | |
- | | + | |
- | •
| + | |
- | Most are idiopathic … genetic susceptibility
| + | |
- | | + | |
- | •
| + | |
- | A very small subset are drug-induced Pathogenesis
| + | |
- | | + | |
- | •
| + | |
- | Definite role of UV radiation in disease induction
| + | |
- | | + | |
- | •
| + | |
- | Complement membrane attack complex (MAC) has role
| + | |
- | | + | |
- | | + | |
- | | + | |
- | | + | |
- | Dermatomyositis Diagnostic Criteria
| + | |
- | Bohan & Peters criteria for diagnosis of dermatomyositis •
| + | |
- | Characteristic skin features
| + | |
- | | + | |
- | •
| + | |
- | Proximal muscle weakness (usually painless)
| + | |
- | | + | |
- | •
| + | |
- | Muscle enzyme abnormalties (CPK, aldolase)
| + | |
- | | + | |
- | •
| + | |
- | Characteristic EMG abnormalities
| + | |
- | | + | |
- | •
| + | |
- | Muscle biopsy … currently MRI commonly used to dx muscle disease **Each of these steps has some degree of limitation; in
| + | |
- | | + | |
- | addition, do not need all 5 dx criteria to make diagnosis
| + | |
- | | + | |
- | | + | |
- | | + | |
- | | + | |
- | Dermatomyositis – Clinical Features Heliotrope rash on upper eyelids
| + | |
- | 12
| + | |
- | | + | |
- | Dermatomyositis – Clinical Features Photosensitivity, tendency towards poikiloderma, “spillover”
| + | |
- | 13
| + | |
- | | + | |
- | What is “Poikiloderma” ?
| + | |
- | Hyperpigmentation Hypopigmentation Telangiectasias Atrophy Most commonly seen with … Dermatomyositis UV radiation damage
| + | |
- | | + | |
- | Ionizing radiation damage
| + | |
- | | + | |
- | Dermatomyositis – Clinical Features Gottron’s papules, periungual telangiectasias
| + | |
- | 14
| + | |
- | | + | |
- | Dermatomyositis – Clinical Features Gottron’s papules over IP joints, sparing between “knuckles”
| + | |
- | 15
| + | |
- | | + | |
- | Diagnosis of Cutaneous Drug Reactions Background Information
| + | |
- | Key realities •
| + | |
- | Virtually any inflammatory cutaneous reaction pattern can be drug-induced at times
| + | |
- | | + | |
- | •
| + | |
- | Seldom does the clinical appearance alone point to a drug etiology (without aid of additional clinical information) Higher risk
| + | |
- | | + | |
- | drug reaction patterns can either cause …
| + | |
- | | + | |
- | •
| + | |
- | Fatal outcome (even if only remotely possible)
| + | |
- | | + | |
- | •
| + | |
- | Significant, irreversible morbidity
| + | |
- | | + | |
- | | + | |
- | | + | |
- | | + | |
- | Diagnosis of Cutaneous Drug Reactions Higher Risk Drug Reaction Patterns
| + | |
- | Urticaria / Anaphylaxis Erythema multiforme major Stevens-Johnson syndrome Toxic epidermal necrolysis Morbilliform reactions
| + | |
- | | + | |
- | with “hypersensitivity syndrome” Vasculitis … and the rest are relatively low risk (vast majority of rxn)
| + | |
- | | + | |
- | Diagnosis of Cutaneous Drug Reactions An Algorithm
| + | |
- | Challenge •
| + | |
- | Timing of drug administration
| + | |
- | | + | |
- | •
| + | |
- | Literature reputation
| + | |
- | | + | |
- | •
| + | |
- | Personal experience (… the least important component) Dechallenge
| + | |
- | | + | |
- | •
| + | |
- | Response to drug cessation
| + | |
- | | + | |
- | •
| + | |
- | Optional – not if essential drug; no help if rxn irreversible Rechallenge
| + | |
- | | + | |
- | •
| + | |
- | Gives highest level of certainty of algorithm steps
| + | |
- | | + | |
- | •
| + | |
- | Optional – not if higher risk pattern, not if alternative Rx Exclusion (of non-drug causes of same pattern)
| + | |
- | | + | |
- | | + | |
- | | + | |
- | | + | |
- |
| + | |
- | It does not get any better than this …
| + | |
- | | + | |
- |
| + | |
- | Thank you for your interest !!
| + | |
R5Wral Say, you got a nice article.Much thanks again.